EPISODE · Feb 2, 2026 · 23 MIN
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
from Neuro-Oncology: The Podcast · host Drs. Iyad Alnahhas, David Schiff, Ranjit Bindra
Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.
NOW PLAYING
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m